Cardio-Renal- Metabolic (CRM) Case Study Series
Cardio-renal-metabolic (CRM) syndrome, which involves type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), and heart failure (HF), is a serious healthcare issue globally, with high morbidity and mortality.
Cardiorenal syndrome can cause a range of severe symptoms and lead to long-term organ damage. The condition can affect a person’s lifespan. While full recovery is unlikely, treatment can reduce symptoms and support the functioning of the heart and kidneys.
This series will tackle the important aspects of care of patients with cardio-renal-metabolic conditions, focusing on the importance of early diagnosis and development of protection and management strategies. The objective being to improve knowledge and increase confidence for primary care professionals, which in turn will improve patient outcomes.
Throughout these expert case presentations, interactive CPD question modules and reflection, you can test your knowledge on how you decide to treat the patients.
Programme agenda
Sept ’24
Pre-programme questionnaire
Mid-Sept ’24
Case 1: T2DM presenting with a catastrophic stroke: Identifying and learning from missed opportunities
A patient with T2DM presenting with a catastrophic stroke – reverse case study demonstrating suboptimal renal surveillance and protection with a focus on lipid and BP measurement and latest guidelines.
Mid-Oct ’24
Case 2: T2DM presenting with heart failure complicated by CKD: Identifying and learning from missed opportunities
A patient with T2DM presenting with heart failure complicated by CKD – reverse case study demonstrating inappropriate exclusion of SGLT2i and highlighting NICE TA for SGLT2i in HF and CKD. Reinforcing simple dosing and eGFR cut offs for initiation, examining new data and NICE TA for HFpEF as well as HFrEF.
Mid-Nov ’24
Case 3: T2DM and early DKD presenting with a fatal myocardial infarction: Identifying and learning from missed opportunities
A patient with T2DM and early DKD presenting with a fatal myocardial infarction – reverse case study investigating optimal secondary prevention strategies, relevance of EMPA-REG OUTCOME and also relevance of cohort studied in EMPA-KIDNEY.
End Nov ’24
Post-programme questionnaire
Your expert for the series
Dr Yassir Javaid
GPwSI Cardiology & Cardiovascular lead
Cardio-Renal-Metabolic case study series
Previously in the CRM series
Watch the on-demand webinars with CPD modules
Part 1 – Consequences of a late diagnosis of diabetic kidney disease
Late diagnosis of diabetic kidney disease patient, reinforcing the current evidence and guidance on early diagnosis and renal protection strategies.
Part 2 – Optimising renal protection in non-diabetic kidney disease
Patient with non-diabetic CKD (hypertensive) – focusing on establishing a diagnosis, thresholds for referral and optimising renal protection in non-diabetic kidney disease
This educational programme has been supported by:
Boehringer Ingelheim and Lilly Alliance has provided funding towards this independent Programme. The Alliance has had no editorial input into or influence on the agenda and content of these case studies including the selection of the author(s).
The content, opinions and statements made in this programme are those of the author(s) and do not necessarily reflect the views of the supporters, editors or editorial board
